Similarly, AHR activation in keratinocytes restores the skin barrier by upregulating epidermal differentiation genes (loricrin and involucrin) and inhibits oxidative stress via Nrf2 signaling, thereby alleviating skin disorders like psoriasis and atopic dermatitis [41, 42]. This evidence concerns the gene NFE2L2 and atopic eczema.